Source:http://linkedlifedata.com/resource/pubmed/id/18591774
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2008-7-1
|
pubmed:abstractText |
Angiotensin II (Ang II) is an important mediator stimulating liver fibrosis after liver injury. However, it is not known whether Ang II plays a role in liver regeneration. Here, we investigate the effects of Ang II type 1 (AT(1)) receptor blocker (ARB), angiotensin-converting enzyme inhibitor (ACEI), systemic infusion of Ang II, and genetic deficiency of the AT(1a) receptor (AT1a-KO) on the hepatic regenerative response to partial hepatectomy (PH) in mice. Administration of ARB (candesartan cilexetil and losartan) or ACEI (enarapril and lisinopril) enhanced 5-bromo-2'-deoxyuridine (BrdU) incorporation into hepatocyte nuclei in remnant liver as well as the restoration of liver weight after PH. Systemic infusion of Ang II (100 ng/kg/min) suppressed the PH-induced BrdU incorporation and the restoration of liver weight. In contrast to Ang II infusion, these hepatic responses to PH were significantly greater in AT1a-KO mice than in wild-type mice. The PH-induced increases in hepatic levels of hepatocyte growth factor (HGF) mRNA and plasma HGF concentrations were greater in candesartan- and enarapril-treated mice or in AT1a-KO mice than in vehicle-treated mice or wild-type mice, respectively, whereas they were less in Ang II-infused mice than in vehicle-infused mice. In contrast to HGF, blockades of the renin-angiotensin system or Ang II infusion produced opposite effects on the PH-induce increases in hepatic transforming growth factor (TGF)-beta 1 mRNA and plasma TGF-beta 1 levels. These studies suggest that Ang II plays a role in the liver regeneration as a suppressor of hepatocyte proliferation via the AT(1) receptor-mediated control of growth factor production.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor...,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites,
http://linkedlifedata.com/resource/pubmed/chemical/Bromodeoxyuridine,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0918-6158
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1356-61
|
pubmed:meshHeading |
pubmed-meshheading:18591774-Angiotensin II,
pubmed-meshheading:18591774-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:18591774-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:18591774-Animals,
pubmed-meshheading:18591774-Antimetabolites,
pubmed-meshheading:18591774-Blotting, Northern,
pubmed-meshheading:18591774-Bromodeoxyuridine,
pubmed-meshheading:18591774-Hepatectomy,
pubmed-meshheading:18591774-Hepatocyte Growth Factor,
pubmed-meshheading:18591774-Liver Regeneration,
pubmed-meshheading:18591774-Male,
pubmed-meshheading:18591774-Mice,
pubmed-meshheading:18591774-RNA, Messenger,
pubmed-meshheading:18591774-Receptor, Angiotensin, Type 1,
pubmed-meshheading:18591774-Renin-Angiotensin System,
pubmed-meshheading:18591774-Transforming Growth Factor beta1
|
pubmed:year |
2008
|
pubmed:articleTitle |
Angiotensin II regulates liver regeneration via type 1 receptor following partial hepatectomy in mice.
|
pubmed:affiliation |
Laboratory of Cardiovascular Pharmacology, Department of Biopharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|